Rising prescription costs and pharmacy closures are making it harder for many Americans to afford and access their ...
The deal, with Eli Lilly and Novo Nordisk, is expected to lower the price of obesity drugs to between $149 and $350 per month ...
The Centers for Medicare & Medicaid Services (CMS) late last week announced the creation of the GENErating cost Reductions for US (GENEROUS) Medicaid Model, which will utilize most-favored nation ...
12d
Lilly, Novo near White House deals to cut obesity drug prices, gain Medicare access, media reports
Eli Lilly and Novo Nordisk are expected to announce deals with the White House to offer the lowest dose of their weight-loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback